TY - JOUR
T1 - An efficient cell-free protein synthesis platform for producing proteins with pyrrolysine-based noncanonical amino acids
AU - Ranji Charna, Arnaz
AU - Des Soye, Benjamin J.
AU - Ntai, Ioanna
AU - Kelleher, Neil L
AU - Jewett, Michael C.
N1 - Funding Information:
This work was supported by the National Science Foundation (NSF) (MCB‐1716766), the Army Research Office (W911NF‐20‐1‐0195, W911NF‐18‐1‐0200), Army Contracting Command (W52P1J‐21‐9‐3023), and the David and Lucile Packard Foundation (2011‐37152). This research was also carried out in collaboration with the National Resource for Translational and Developmental Proteomics under Grant P41 GM108569 from the National Institute of General Medical Sciences, National Institutes of Health and supported by the Sherman Fairchild Foundation. The ncAA synthesis was completed by Christopher Holmquist at ChemCore in the Center for Molecular Innovation and Drug Discovery which is supported in part by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The authors would like to thank Dr. Farren Isaacs for the kind gift of the genomically recoded strain; Dr. Javin Oza for cloning of the sfGFP2TAG plasmid; Dr. Seok Hoon Hong for cloning the sfGFP5TAG plasmid; Alaksh Choudhury for help with Matlab coding; Mark Anderson for assistance with Chemdraw; and Dr. E. Lemke for plasmid pEvolPylRSWT. E. coli
Publisher Copyright:
© 2022 Wiley-VCH GmbH.
PY - 2022/9
Y1 - 2022/9
N2 - Incorporation of noncanonical amino acids (ncAAs) into proteins opens new opportunities in biotechnology and synthetic biology. Pyrrolysine (Pyl)-based ncAAs are some of the most predominantly used, but expression systems suffer from low yields. Here, we report a highly efficient cell-free protein synthesis (CFPS) platform for site-specific incorporation of Pyl-based ncAAs into proteins using amber suppression. This platform is based on cellular extracts derived from genomically recoded Escherichia coli lacking release factor 1 and enhanced through deletion of endonuclease A. To enable ncAA incorporation, orthogonal translation system (OTS) components (i.e., the orthogonal transfer RNA [tRNA] and orthogonal aminoacyl tRNA synthetase) were coexpressed in the source strain prior to lysis and the orthogonal tRNACUAPyl that decodes the amber codon was further enriched in the CFPS reaction via co-synthesis with the product. Using this platform, we demonstrate production of up to 442 ± 23 µg/mL modified superfolder green fluorescent protein (sfGFP) containing a single Pyl-based ncAA at high (>95%) suppression efficiency, as well as sfGFP variants harboring multiple, identical ncAAs. Our CFPS platform can be used for the synthesis of modified proteins containing multiple precisely positioned, genetically encoded Pyl-based ncAAs. We anticipate that it will facilitate more general use of CFPS in synthetic biology.
AB - Incorporation of noncanonical amino acids (ncAAs) into proteins opens new opportunities in biotechnology and synthetic biology. Pyrrolysine (Pyl)-based ncAAs are some of the most predominantly used, but expression systems suffer from low yields. Here, we report a highly efficient cell-free protein synthesis (CFPS) platform for site-specific incorporation of Pyl-based ncAAs into proteins using amber suppression. This platform is based on cellular extracts derived from genomically recoded Escherichia coli lacking release factor 1 and enhanced through deletion of endonuclease A. To enable ncAA incorporation, orthogonal translation system (OTS) components (i.e., the orthogonal transfer RNA [tRNA] and orthogonal aminoacyl tRNA synthetase) were coexpressed in the source strain prior to lysis and the orthogonal tRNACUAPyl that decodes the amber codon was further enriched in the CFPS reaction via co-synthesis with the product. Using this platform, we demonstrate production of up to 442 ± 23 µg/mL modified superfolder green fluorescent protein (sfGFP) containing a single Pyl-based ncAA at high (>95%) suppression efficiency, as well as sfGFP variants harboring multiple, identical ncAAs. Our CFPS platform can be used for the synthesis of modified proteins containing multiple precisely positioned, genetically encoded Pyl-based ncAAs. We anticipate that it will facilitate more general use of CFPS in synthetic biology.
KW - cell-free protein synthesis
KW - chemical biology
KW - genetic code expansion
KW - in vitro transcription and translation
KW - noncanonical amino acids
KW - synthetic biology
UR - http://www.scopus.com/inward/record.url?scp=85131594804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131594804&partnerID=8YFLogxK
U2 - 10.1002/biot.202200096
DO - 10.1002/biot.202200096
M3 - Article
C2 - 35569121
AN - SCOPUS:85131594804
SN - 1860-6768
VL - 17
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 9
M1 - 2200096
ER -